AAAAAA

   
Results: 1-25 | 26-50 | 51-54
Results: 1-25/54
10-YEAR RESULTS OF A RANDOMIZED TRIAL COMPARING 2 CONSERVATIVE TREATMENT STRATEGIES FOR SMALL-SIZE BREAST-CANCER
Authors: MARIANI L SALVADORI B MARUBINI E CONTI AR ROVINI D CUSUMANO F ROSOLIN T ANDREOLA S ZUCALI R RILKE F VERONESI U
Citation: L. Mariani et al., 10-YEAR RESULTS OF A RANDOMIZED TRIAL COMPARING 2 CONSERVATIVE TREATMENT STRATEGIES FOR SMALL-SIZE BREAST-CANCER, European journal of cancer, 34(8), 1998, pp. 1156-1162
BRCA1 AND BRCA2 GERMLINE MUTATIONS IN EARLY-ONSET BREAST-CARCINOMA PATIENTS
Authors: CONTI AR DEBENEDETTI MVG STAGI L MONDINI P PASINI B PENSOTTI V SPATTI GB RILKE F PIEROTTI MA RADICE P
Citation: Ar. Conti et al., BRCA1 AND BRCA2 GERMLINE MUTATIONS IN EARLY-ONSET BREAST-CARCINOMA PATIENTS, European journal of cancer, 34, 1998, pp. 7-7
EVALUATION OF RESIDUAL CELLULARITY AND PROLIFERATION ON PREOPERATIVELY TREATED BREAST-CANCER - A COMPARISON BETWEEN IMAGE-ANALYSIS AND LIGHT-MICROSCOPY ANALYSIS
Authors: CORLETTO V VERDERIO P GIARDINI R CIPRIANI S DIPALMA S RILKE F
Citation: V. Corletto et al., EVALUATION OF RESIDUAL CELLULARITY AND PROLIFERATION ON PREOPERATIVELY TREATED BREAST-CANCER - A COMPARISON BETWEEN IMAGE-ANALYSIS AND LIGHT-MICROSCOPY ANALYSIS, Analytical cellular pathology, 16(2), 1998, pp. 83-93
EARLY BREAST-CANCER - EVALUATION OF THE PROGNOSTIC ROLE OF THE SITE OF THE PRIMARY TUMOR
Authors: ZUCALI R MARIANI L MARUBINI E KENDA R LOZZA L RILKE F VERONESI U
Citation: R. Zucali et al., EARLY BREAST-CANCER - EVALUATION OF THE PROGNOSTIC ROLE OF THE SITE OF THE PRIMARY TUMOR, Journal of clinical oncology, 16(4), 1998, pp. 1363-1366
MOLECULAR ABNORMALITIES IN LIPOSARCOMA - ROLE OF MDM2 AND CDK4-CONTAINING AMPLICONS AT 12Q13-22
Authors: PILOTTI S DELLATORRE G LAVARINO C SOZZI G MINOLETTI F VERGANI B AZZARELLI A RILKE F PIEROTTI MA
Citation: S. Pilotti et al., MOLECULAR ABNORMALITIES IN LIPOSARCOMA - ROLE OF MDM2 AND CDK4-CONTAINING AMPLICONS AT 12Q13-22, Journal of pathology, 185(2), 1998, pp. 188-190
BCL-2 EXPRESSION IN SYNOVIAL SARCOMA
Authors: PILOTTI S MEZZELANI A AZZARELLI A RILKE F PIEROTTI MA
Citation: S. Pilotti et al., BCL-2 EXPRESSION IN SYNOVIAL SARCOMA, Journal of pathology, 184(3), 1998, pp. 337-338
THYROID PAPILLARY CARCINOMA OF COLUMNAR CELL-TYPE - A CLINICOPATHOLOGICAL STUDY OF 16 CASES
Authors: PILOTTI S COLLINI P SAMPIETRO G MANZARI A MARUBINI E RILKE F
Citation: S. Pilotti et al., THYROID PAPILLARY CARCINOMA OF COLUMNAR CELL-TYPE - A CLINICOPATHOLOGICAL STUDY OF 16 CASES, Cancer, 83(11), 1998, pp. 2421-2422
DETECTION OF TP53 MUTATION, LOSS OF HETEROZYGOSITY AND DNA CONTENT INFINE-NEEDLE ASPIRATES OF BREAST-CARCINOMA
Authors: LAVARINO C CORLETTO V MEZZELANI A DELLATORRE G BARTOLI C RIVA C PIEROTTI MA RILKE F PILOTTI S
Citation: C. Lavarino et al., DETECTION OF TP53 MUTATION, LOSS OF HETEROZYGOSITY AND DNA CONTENT INFINE-NEEDLE ASPIRATES OF BREAST-CARCINOMA, British Journal of Cancer, 77(1), 1998, pp. 125-130
LYMPHOID INFILTRATION AS A PROGNOSTIC VARIABLE FOR EARLY-ONSET BREASTCARCINOMAS
Authors: MENARD S TOMASIC G CASALINI P BALSARI A PILOTTI S CASCINELLI N SALVADORI B COLNAGHI MI RILKE F
Citation: S. Menard et al., LYMPHOID INFILTRATION AS A PROGNOSTIC VARIABLE FOR EARLY-ONSET BREASTCARCINOMAS, Clinical cancer research, 3(5), 1997, pp. 817-819
IMMUNOCYTOCHEMICAL MARKERS IN STAGE-I LUNG-CANCER - RELEVANCE TO PROGNOSIS
Authors: PASTORINO U ANDREOLA S TAGLIABUE E PEZZELLA F INCARBONE M SOZZI G BUYSE M MENARD S PIEROTTI M RILKE F
Citation: U. Pastorino et al., IMMUNOCYTOCHEMICAL MARKERS IN STAGE-I LUNG-CANCER - RELEVANCE TO PROGNOSIS, Journal of clinical oncology, 15(8), 1997, pp. 2858-2865
EFFICACY, TOXICITY, AND APPLICABILITY OF HIGH-DOSE SEQUENTIAL CHEMOTHERAPY AS ADJUVANT TREATMENT IN OPERABLE BREAST-CANCER WITH 10 OR MORE INVOLVED AXILLARY NODES - 5-YEAR RESULTS
Authors: GIANNI AM SIENA S BREGNI M DINICOLA M OREFICE S CUSUMANO F SALVADORI B LUINI A GRECO M ZUCALI R RILKE F ZAMBETTI M VALAGUSSA P BONADONNA G
Citation: Am. Gianni et al., EFFICACY, TOXICITY, AND APPLICABILITY OF HIGH-DOSE SEQUENTIAL CHEMOTHERAPY AS ADJUVANT TREATMENT IN OPERABLE BREAST-CANCER WITH 10 OR MORE INVOLVED AXILLARY NODES - 5-YEAR RESULTS, Journal of clinical oncology, 15(6), 1997, pp. 2312-2321
SURVIVAL OF CANCER-PATIENTS IN ITALY THE ITACARE STUDY - FOREWORD
Authors: RILKE F
Citation: F. Rilke, SURVIVAL OF CANCER-PATIENTS IN ITALY THE ITACARE STUDY - FOREWORD, Tumori, 83(1), 1997, pp. 28-28
PROGNOSTIC FACTORS FOR METACHRONOUS CONTRALATERAL BREAST-CANCER - A COMPARISON OF THE LINEAR COX REGRESSION-MODEL AND ITS ARTIFICIAL NEURAL-NETWORK EXTENSION
Authors: MARIANI L CORADINI D BIGANZOLI E BORACCHI P MARUBINI E PILOTTI S SALVADORI B SILVESTRINI R VERONESI U ZUCALI R RILKE F
Citation: L. Mariani et al., PROGNOSTIC FACTORS FOR METACHRONOUS CONTRALATERAL BREAST-CANCER - A COMPARISON OF THE LINEAR COX REGRESSION-MODEL AND ITS ARTIFICIAL NEURAL-NETWORK EXTENSION, Breast cancer research and treatment, 44(2), 1997, pp. 167-178
INSULAR CARCINOMA - A DISTINCT DE-NOVO ENTITY AMONG FOLLICULAR CARCINOMAS OF THE THYROID-GLAND
Authors: PILOTTI S COLLINI P MARIANI L PLACUCCI M BONGARZONE I VIGNERI P CIPRIANI S FALCETTA F PIEROTTI MA RILKE F
Citation: S. Pilotti et al., INSULAR CARCINOMA - A DISTINCT DE-NOVO ENTITY AMONG FOLLICULAR CARCINOMAS OF THE THYROID-GLAND, The American journal of surgical pathology, 21(12), 1997, pp. 1466-1473
DISTINCT MDM2 P53 EXPRESSION PATTERNS IN LIPOSARCOMA SUBGROUPS - IMPLICATIONS FOR DIFFERENT PATHOGENETIC MECHANISMS/
Authors: PILOTTI S DELLATORRE G LAVARINO C DIPALMA S SOZZI G MINOLETTI F RAO S PASQUINI G AZZARELLI A RILKE F PIEROTTI MA
Citation: S. Pilotti et al., DISTINCT MDM2 P53 EXPRESSION PATTERNS IN LIPOSARCOMA SUBGROUPS - IMPLICATIONS FOR DIFFERENT PATHOGENETIC MECHANISMS/, Journal of pathology, 181(1), 1997, pp. 14-24
CONSERVATIVE SURGERY FOR INFILTRATING LOBULAR BREAST-CARCINOMA
Authors: SALVADORI B BIGANZOLI E VERONESI P SACCOZZI R RILKE F
Citation: B. Salvadori et al., CONSERVATIVE SURGERY FOR INFILTRATING LOBULAR BREAST-CARCINOMA, British Journal of Surgery, 84(1), 1997, pp. 106-109
NON-SMALL-CELL LUNG-CARCINOMA TUMOR-GROWTH WITHOUT MORPHOLOGICAL EVIDENCE OF NEO-ANGIOGENESIS
Authors: PEZZELLA F PASTORINO U TAGLIABUE E ANDREOLA S SOZZI G GASPARINI G MENARD S GATTER KC HARRIS AL FOX S BUYSE M PILOTTI S PIEROTTI M RILKE F
Citation: F. Pezzella et al., NON-SMALL-CELL LUNG-CARCINOMA TUMOR-GROWTH WITHOUT MORPHOLOGICAL EVIDENCE OF NEO-ANGIOGENESIS, The American journal of pathology, 151(5), 1997, pp. 1417-1423
NO ADDITIVE IMPACT ON PATIENT SURVIVAL OF THE DOUBLE ALTERATION OF P53 AND C-ERBB-2 IN BREAST CARCINOMAS
Authors: MENARD S CASALINI P PILOTTI S CASCINELLI N RILKE F COLNAGHI MI
Citation: S. Menard et al., NO ADDITIVE IMPACT ON PATIENT SURVIVAL OF THE DOUBLE ALTERATION OF P53 AND C-ERBB-2 IN BREAST CARCINOMAS, Journal of the National Cancer Institute, 88(14), 1996, pp. 1002-1003
RELATIONSHIP OF HISTOLOGIC GRADE, C-ERBB-2 EXPRESSION, AND INFLAMMATORY INFILTRATE TO PROGNOSIS IN CARCINOMA OF THE BREAST
Authors: MENARD S PUPA SM CASALINI P RILKE F COLNAGHI MI
Citation: S. Menard et al., RELATIONSHIP OF HISTOLOGIC GRADE, C-ERBB-2 EXPRESSION, AND INFLAMMATORY INFILTRATE TO PROGNOSIS IN CARCINOMA OF THE BREAST, Journal of clinical oncology, 14(8), 1996, pp. 2406-2407
RELATIONSHIP OF HISTOLOGIC GRADE, C-ERBB-2 EXPRESSION, AND INFLAMMATORY INFILTRATE TO PROGNOSIS IN CARCINOMA OF THE BREAST - IN REPLY
Authors: MENARD S PUPA SM CASALINI P RILKE F COLNAGHI MI
Citation: S. Menard et al., RELATIONSHIP OF HISTOLOGIC GRADE, C-ERBB-2 EXPRESSION, AND INFLAMMATORY INFILTRATE TO PROGNOSIS IN CARCINOMA OF THE BREAST - IN REPLY, Journal of clinical oncology, 14(8), 1996, pp. 2407-2407
MACROPHAGE INFILTRATE AND PROGNOSIS IN C-ERBB-2-OVEREXPRESSING BREASTCARCINOMAS
Authors: PUPA SM BUFALINO R INVERNIZZI AM ANDREOLA S RILKE F LOMBARDI L COLNAGHI MI MENARD S
Citation: Sm. Pupa et al., MACROPHAGE INFILTRATE AND PROGNOSIS IN C-ERBB-2-OVEREXPRESSING BREASTCARCINOMAS, Journal of clinical oncology, 14(1), 1996, pp. 85-94
RESULTS OF A BREAST-CANCER-SURGERY TRIAL COMPARED WITH OBSERVATIONAL DATA FROM ROUTINE PRACTICE
Authors: MARUBINI E MARIANI L SALVADORI B VERONESI U SACCOZZI R MERSON M ZUCALI R RILKE F
Citation: E. Marubini et al., RESULTS OF A BREAST-CANCER-SURGERY TRIAL COMPARED WITH OBSERVATIONAL DATA FROM ROUTINE PRACTICE, Lancet, 347(9007), 1996, pp. 1000-1003
DOUSING THE FLAME
Authors: CROSIGNANI P BERRINO F RILKE F
Citation: P. Crosignani et al., DOUSING THE FLAME, Nature, 383(6603), 1996, pp. 756-756
COMPUTER-ASSISTED QUALITY ASSURANCE
Authors: WIED GL BARTELS PH BIBBO M GUPTA PK GURLEY AM HILGARTH M JIMENEZAYALA M KATO H KNIGHT BK MCGOOGAN E MEDLEY G MEISELS A NISHIYA I NOZAWA S RAMZY I REITH A RILKE F RIVERAPOMAR JM ROSENTHAL DL SCHENCK U VERHEST AP VOOIJS GP
Citation: Gl. Wied et al., COMPUTER-ASSISTED QUALITY ASSURANCE, Acta cytologica, 40(1), 1996, pp. 1-3
PREDICTION OF AXILLARY LYMPH-NODE STATUS IN BREAST-CANCER PATIENTS BYUSE OF PROGNOSTIC INDICATORS
Authors: MENARD S CASCINELLI N RILKE F COLNAGHI MI
Citation: S. Menard et al., PREDICTION OF AXILLARY LYMPH-NODE STATUS IN BREAST-CANCER PATIENTS BYUSE OF PROGNOSTIC INDICATORS, Journal of the National Cancer Institute, 87(8), 1995, pp. 607-607
Risultati: 1-25 | 26-50 | 51-54